AMGXF
Price
$0.36
Change
-$0.05 (-12.20%)
Updated
Dec 5 closing price
Capitalization
244.21M
SCNI
Price
$1.50
Change
-$0.06 (-3.85%)
Updated
Sep 5 closing price
Capitalization
1.5M
Interact to see
Advertisement

AMGXF vs SCNI

Header iconAMGXF vs SCNI Comparison
Open Charts AMGXF vs SCNIBanner chart's image
AnGes MG
Price$0.36
Change-$0.05 (-12.20%)
Volume$2.05K
Capitalization244.21M
Scinai Immunotherapeutics
Price$1.50
Change-$0.06 (-3.85%)
Volume$84.75K
Capitalization1.5M
AMGXF vs SCNI Comparison Chart in %
Loading...
SCNI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMGXF vs. SCNI commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMGXF is a Hold and SCNI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (AMGXF: $0.36 vs. SCNI: $1.50)
Brand notoriety: AMGXF and SCNI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMGXF: 100% vs. SCNI: 6%
Market capitalization -- AMGXF: $244.21M vs. SCNI: $1.5M
AMGXF [@Biotechnology] is valued at $244.21M. SCNI’s [@Biotechnology] market capitalization is $1.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMGXF’s FA Score shows that 0 FA rating(s) are green whileSCNI’s FA Score has 2 green FA rating(s).

  • AMGXF’s FA Score: 0 green, 5 red.
  • SCNI’s FA Score: 2 green, 3 red.
According to our system of comparison, SCNI is a better buy in the long-term than AMGXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SCNI’s TA Score shows that 4 TA indicator(s) are bullish.

  • SCNI’s TA Score: 4 bullish, 2 bearish.

Price Growth

AMGXF (@Biotechnology) experienced а 0.00% price change this week, while SCNI (@Biotechnology) price change was -1.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMGXF($244M) has a higher market cap than SCNI($1.5M). AMGXF YTD gains are higher at: 0.000 vs. SCNI (-55.157). SCNI has higher annual earnings (EBITDA): 7.8M vs. AMGXF (-4.7B). AMGXF has more cash in the bank: 2.91B vs. SCNI (1.03M). SCNI has less debt than AMGXF: SCNI (1.23M) vs AMGXF (199M). AMGXF has higher revenues than SCNI: AMGXF (711M) vs SCNI (452K).
AMGXFSCNIAMGXF / SCNI
Capitalization244M1.5M16,267%
EBITDA-4.7B7.8M-60,246%
Gain YTD0.000-55.157-
P/E RatioN/A0.38-
Revenue711M452K157,301%
Total Cash2.91B1.03M281,783%
Total Debt199M1.23M16,218%
FUNDAMENTALS RATINGS
AMGXF vs SCNI: Fundamental Ratings
AMGXF
SCNI
OUTLOOK RATING
1..100
5044
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
14
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
1007
PRICE GROWTH RATING
1..100
5792
P/E GROWTH RATING
1..100
10099
SEASONALITY SCORE
1..100
302

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SCNI's Valuation (14) in the Pharmaceuticals Major industry is somewhat better than the same rating for AMGXF (56) in the null industry. This means that SCNI’s stock grew somewhat faster than AMGXF’s over the last 12 months.

SCNI's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as AMGXF (100) in the null industry. This means that SCNI’s stock grew similarly to AMGXF’s over the last 12 months.

SCNI's SMR Rating (7) in the Pharmaceuticals Major industry is significantly better than the same rating for AMGXF (100) in the null industry. This means that SCNI’s stock grew significantly faster than AMGXF’s over the last 12 months.

AMGXF's Price Growth Rating (57) in the null industry is somewhat better than the same rating for SCNI (92) in the Pharmaceuticals Major industry. This means that AMGXF’s stock grew somewhat faster than SCNI’s over the last 12 months.

SCNI's P/E Growth Rating (99) in the Pharmaceuticals Major industry is in the same range as AMGXF (100) in the null industry. This means that SCNI’s stock grew similarly to AMGXF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMGXFSCNI
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
77%
Stochastic
ODDS (%)
N/A
Bullish Trend 3 days ago
89%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
5%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
5%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
78%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
SCNI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FGFRX43.880.26
+0.60%
Federated Hermes Intl Leaders R
RYPAX53.080.31
+0.59%
Rydex Transportation H
ASQGX17.860.02
+0.11%
American Century Small Company R5
HIGJX21.92N/A
N/A
Carillon Eagle Growth & Income I
PWJAX34.26N/A
N/A
PGIM Jennison International Opps A

AMGXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMGXF has been loosely correlated with ATON. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if AMGXF jumps, then ATON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMGXF
1D Price
Change %
AMGXF100%
N/A
ATON - AMGXF
34%
Loosely correlated
-6.61%
APLT - AMGXF
33%
Loosely correlated
+1.87%
TLSA - AMGXF
21%
Poorly correlated
+5.06%
SCNI - AMGXF
21%
Poorly correlated
-3.85%
ABVC - AMGXF
3%
Poorly correlated
-2.57%
More

SCNI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCNI has been closely correlated with TAOX. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if SCNI jumps, then TAOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCNI
1D Price
Change %
SCNI100%
-3.85%
TAOX - SCNI
73%
Closely correlated
+6.91%
SYRE - SCNI
43%
Loosely correlated
+0.06%
MBIO - SCNI
37%
Loosely correlated
-2.72%
BIVI - SCNI
34%
Loosely correlated
+9.43%
VANI - SCNI
32%
Poorly correlated
-5.84%
More